{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:06:54Z","timestamp":1790766414163,"version":"4.1.0"},"reference-count":90,"publisher":"The Microbiological Society of Korea","issue":"3","license":[{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Microbiol."],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12275-022-1525-1","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T08:13:43Z","timestamp":1644048823000},"page":"290-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways"],"prefix":"10.71150","volume":"60","author":[{"given":"Soo-Jin","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ok Sarah","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4586","published-online":{"date-parts":[[2022,2,5]]},"reference":[{"key":"1525_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41577-020-0346-x","volume":"20","author":"D Acharya","year":"2020","unstructured":"Acharya, D., Liu, G., and Gack, M.U. 2020. Dysregulation of type I interferon responses in COVID-19. Nat. Rev. Immunol. 20, 397\u2013398.","journal-title":"Nat. Rev. Immunol."},{"key":"1525_CR2","doi-asserted-by":"crossref","first-page":"e00065","DOI":"10.1128\/mBio.00065-21","volume":"12","author":"A Addetia","year":"2021","unstructured":"Addetia, A., Lieberman, N.A.P., Phung, Q., Hsiang, T.Y., Xie, H., Roychoudhury, P., Shrestha, L., Loprieno, M.A., Huang, M.L., Gale, M. Jr., et al. 2021. SARS-CoV-2 ORF6 disrupts bidirectional nucleocytoplasmic transport through interactions with Rae1 and Nup98. mBio 12, e00065\u201321.","journal-title":"mBio"},{"key":"1525_CR3","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.cell.2020.10.004","volume":"183","author":"AK Banerjee","year":"2020","unstructured":"Banerjee, A.K., Blanco, M.R., Bruce, E.A., Honson, D.D., Chen, L.M., Chow, A., Bhat, P., Ollikainen, N., Quinodoz, S.A., Loney, C., et al. 2020. SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell 183, 1325\u20131339.","journal-title":"Cell"},{"key":"1525_CR4","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard, P., Rosen, L.B., Zhang, Q., Michailidis, E., Hoffmann, H.H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., B\u00e9ziat, V., et al. 2020. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585.","journal-title":"Science"},{"key":"1525_CR5","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D., Nilsson-Payant, B.E., Liu, W.C., Uhl, S., Hoagland, D., M\u00f8ller, R., Jordan, T.X., Oishi, K., Panis, M., Sachs, D., et al. 2020. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045.","journal-title":"Cell"},{"key":"1525_CR6","doi-asserted-by":"crossref","first-page":"e01928","DOI":"10.1128\/mBio.01928-20","volume":"11","author":"I Busnadiego","year":"2020","unstructured":"Busnadiego, I., Fernbach, S., Pohl, M.O., Karakus, U., Huber, M., Trkola, A., Stertz, S., and Hale, B.G. 2020. Antiviral activity of type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2. mBio 11, e01928\u201320.","journal-title":"mBio"},{"key":"1525_CR7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41423-020-00603-6","volume":"18","author":"Z Cao","year":"2021","unstructured":"Cao, Z., Xia, H., Rajsbaum, R., Xia, X., Wang, H., and Shi, P.Y. 2021. Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response. Cell. Mol. Immunol. 18, 746\u2013748.","journal-title":"Cell. Mol. Immunol."},{"key":"1525_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/v13010047","volume":"13","author":"K Chen","year":"2020","unstructured":"Chen, K., Xiao, F., Hu, D., Ge, W., Tian, M., Wang, W., Pan, P., Wu, K., and Wu, J. 2020a. SARS-CoV-2 nucleocapsid protein interacts with RIG-I and represses RIG-mediated IFN-\u03b2 production. Viruses 13, 47.","journal-title":"Viruses"},{"key":"1525_CR9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. 2020b. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507\u2013513.","journal-title":"Lancet"},{"key":"1525_CR10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4161\/auto.7.11.16642","volume":"7","author":"EM Cottam","year":"2011","unstructured":"Cottam, E.M., Maier, H.J., Manifava, M., Vaux, L.C., Chandra-Schoenfelder, P., Gerner, W., Britton, P., Ktistakis, N.T., and Wileman, T. 2011. Coronavirus nsp6 proteins generate autophagosomes from the endoplasmic reticulum via an omegasome intermediate. Autophagy 7, 1335\u20131347.","journal-title":"Autophagy"},{"key":"1525_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui, J., Li, F., and Shi, Z.L. 2019. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181\u2013192.","journal-title":"Nat. Rev. Microbiol."},{"key":"1525_CR12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","volume":"180","author":"KA Fitzgerald","year":"2020","unstructured":"Fitzgerald, K.A. and Kagan, J.C. 2020. Toll-like receptors and the control of immunity. Cell 180, 1044\u20131066.","journal-title":"Cell"},{"key":"1525_CR13","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1128\/JVI.01012-07","volume":"81","author":"M Frieman","year":"2007","unstructured":"Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S.A., Palese, P., and Baric, R.S. 2007. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum\/golgi membrane. J. Virol. 81, 9812\u20139824.","journal-title":"J. Virol."},{"key":"1525_CR14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-00571-x","volume":"18","author":"YZ Fu","year":"2021","unstructured":"Fu, Y.Z., Wang, S.Y., Zheng, Z.Q., Huang, Y., Li, W.W., Xu, Z.S., and Wang, Y.Y. 2021. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response. Cell. Mol. Immunol. 18, 613\u2013620.","journal-title":"Cell. Mol. Immunol."},{"key":"1525_CR15","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.7150\/ijbs.59943","volume":"17","author":"SY Fung","year":"2021","unstructured":"Fung, S.Y., Siu, K.L., Lin, H., Yeung, M.L., and Jin, D.Y. 2021. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3. Int. J. Biol. Sci. 17, 1547\u20131554.","journal-title":"Int. J. Biol. Sci."},{"key":"1525_CR16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon, D.E., Jang, G.M., Bouhaddou, M., Xu, J., Obernier, K., White, K.M., O\u2019Meara, M.J., Rezelj, V.V., Guo, J.Z., Swaney, D.L., et al. 2020. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468.","journal-title":"Nature"},{"key":"1525_CR17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/v13081439","volume":"13","author":"G Gori Savellini","year":"2021","unstructured":"Gori Savellini, G., Anichini, G., Gandolfo, C., and Cusi, M.G. 2021. SARS-CoV-2 N protein targets TRIM25-mediated RIG-I activation to suppress innate immunity. Viruses 13, 1439.","journal-title":"Viruses"},{"key":"1525_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41392-021-00509-3","volume":"6","author":"G Guo","year":"2021","unstructured":"Guo, G., Gao, M., Gao, X., Zhu, B., Huang, J., Luo, K., Zhang, Y., Sun, J., Deng, M., and Lou, Z. 2021. SARS-CoV-2 non-structural protein 13 (nsp13) hijacks host deubiquitinase USP13 and counteracts host antiviral immune response. Signal Transduct. Target. Ther. 6, 119.","journal-title":"Signal Transduct. Target. Ther."},{"key":"1525_CR19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., P\u00e9r\u00e9, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. 2020. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724.","journal-title":"Science"},{"key":"1525_CR20","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1002\/jmv.27050","volume":"93","author":"L Han","year":"2021","unstructured":"Han, L., Zhuang, M.W., Deng, J., Zheng, Y., Zhang, J., Nan, M.L., Zhang, X.J., Gao, C., and Wang, P.H. 2021. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I\/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. J. Med. Virol. 93, 5376\u20135389.","journal-title":"J. Med. Virol."},{"key":"1525_CR21","doi-asserted-by":"crossref","first-page":"12910","DOI":"10.1074\/jbc.REV120.013930","volume":"295","author":"E Hartenian","year":"2020","unstructured":"Hartenian, E., Nandakumar, D., Lari, A., Ly, M., Tucker, J.M., and Glaunsinger, B.A. 2020. The molecular virology of coronaviruses. J. Biol. Chem. 295, 12910\u201312934.","journal-title":"J. Biol. Chem."},{"key":"1525_CR22","doi-asserted-by":"crossref","first-page":"109126","DOI":"10.1016\/j.celrep.2021.109126","volume":"35","author":"M Hayn","year":"2021","unstructured":"Hayn, M., Hirschenberger, M., Koepke, L., Nchioua, R., Straub, J.H., Klute, S., Hunszinger, V., Zech, F., Prelli Bozzo, C., Aftab, W., et al. 2021. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. Cell Rep. 35, 109126.","journal-title":"Cell Rep."},{"key":"1525_CR23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kr\u00fcger, N., Herrler, T., Erichsen, S., Schiergens, T.S., Herrler, G., Wu, N.H., Nitsche, A., et al. 2020. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.","journal-title":"Cell"},{"key":"1525_CR24","doi-asserted-by":"crossref","first-page":"e2101161118","DOI":"10.1073\/pnas.2101161118","volume":"118","author":"JCC Hsu","year":"2021","unstructured":"Hsu, J.C.C., Laurent-Rolle, M., Pawlak, J.B., Wilen, C.B., and Cress-well, P. 2021. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein. Proc. Natl. Acad. Sci. USA 118, e2101161118.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1525_CR25","first-page":"e02143","volume":"91","author":"Y Hu","year":"2017","unstructured":"Hu, Y., Li, W., Gao, T., Cui, Y., Jin, Y., Li, P., Ma, Q., Liu, X., and Cao, C. 2017. The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I interferon production by interfering with TRIM25-mediated RIG-I ubiquitination. J. Virol. 91, e02143\u201316.","journal-title":"J. Virol."},{"key":"1525_CR26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506.","journal-title":"Lancet"},{"key":"1525_CR27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41577-020-0321-6","volume":"20","author":"A Iwasaki","year":"2020","unstructured":"Iwasaki, A. and Yang, Y. 2020. The potential danger of suboptimal antibody responses in COVID-19. Nat. Rev. Immunol. 20, 339\u2013341.","journal-title":"Nat. Rev. Immunol."},{"key":"1525_CR28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41423-020-0514-8","volume":"17","author":"HW Jiang","year":"2020","unstructured":"Jiang, H.W., Zhang, H.N., Meng, Q.F., Xie, J., Li, Y., Chen, H., Zheng, Y.X., Wang, X.N., Qi, H., Zhang, J., et al. 2020. SARS-CoV-2 ORF9b suppresses type I interferon responses by targeting TOM70. Cell. Mol. Immunol. 17, 998\u20131000.","journal-title":"Cell. Mol. Immunol."},{"key":"1525_CR29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s12276-021-00602-1","volume":"53","author":"Y Kasuga","year":"2021","unstructured":"Kasuga, Y., Zhu, B., Jang, K.J., and Yoo, J.S. 2021. Innate immune sensing of coronavirus and viral evasion strategies. Exp. Mol. Med. 53, 723\u2013736.","journal-title":"Exp. Mol. Med."},{"key":"1525_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2020.11.115","volume":"536","author":"K Kato","year":"2021","unstructured":"Kato, K., Ikliptikawati, D.K., Kobayashi, A., Kondo, H., Lim, K., Hazawa, M., and Wong, R.W. 2021. Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex. Biochem. Biophys. Res. Commun. 536, 59\u201366.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1525_CR31","doi-asserted-by":"crossref","first-page":"108916","DOI":"10.1016\/j.celrep.2021.108916","volume":"34","author":"I Kimura","year":"2021","unstructured":"Kimura, I., Konno, Y., Uriu, K., Hopfensperger, K., Sauter, D., Nakagawa, S., and Sato, K. 2021. Sarbecovirus ORF6 proteins hamper induction of interferon signaling. Cell Rep. 34, 108916.","journal-title":"Cell Rep."},{"key":"1525_CR32","doi-asserted-by":"crossref","first-page":"e106275","DOI":"10.15252\/embj.2020106275","volume":"39","author":"T Klemm","year":"2020","unstructured":"Klemm, T., Ebert, G., Calleja, D.J., Allison, C.C., Richardson, L.W., Bernardini, J.P., Lu, B.G.C., Kuchel, N.W., Grohmann, C., Shibata, Y., et al. 2020. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2. EMBO J. 39, e106275.","journal-title":"EMBO J."},{"key":"1525_CR33","doi-asserted-by":"crossref","first-page":"108185","DOI":"10.1016\/j.celrep.2020.108185","volume":"32","author":"Y Konno","year":"2020","unstructured":"Konno, Y., Kimura, I., Uriu, K., Fukushi, M., Irie, T., Koyanagi, Y., Sauter, D., Gifford, R.J., USFQ-COVID19 Consortium, Nakagawa, S., et al. 2020. SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant. Cell Rep. 32, 108185.","journal-title":"Cell Rep."},{"key":"1525_CR34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/JVI.01782-06","volume":"81","author":"SA Kopecky-Bromberg","year":"2007","unstructured":"Kopecky-Bromberg, S.A., Mart\u00ednez-Sobrido, L., Frieman, M., Baric, R.A., and Palese, P. 2007. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 81, 548\u2013557.","journal-title":"J. Virol."},{"key":"1525_CR35","doi-asserted-by":"crossref","first-page":"700926","DOI":"10.3389\/fimmu.2021.700926","volume":"12","author":"T Kouwaki","year":"2021","unstructured":"Kouwaki, T., Nishimura, T., Wang, G., and Oshiumi, H. 2021. RIG-I-like receptor-mediated recognition of viral genomic RNA of severe acute respiratory syndrome coronavirus-2 and viral escape from the host innate immune responses. Front. Immunol. 12, 700926.","journal-title":"Front. Immunol."},{"key":"1525_CR36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13337-020-00632-9","volume":"31","author":"S Krishnamoorthy","year":"2020","unstructured":"Krishnamoorthy, S., Swain, B., Verma, R.S., and Gunthe, S.S. 2020. SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDis. 31, 411\u2013423.","journal-title":"VirusDis."},{"key":"1525_CR37","doi-asserted-by":"crossref","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","volume":"5","author":"JS Lee","year":"2020","unstructured":"Lee, J.S., Park, S., Jeong, H.W., Ahn, J.Y., Choi, S.J., Lee, H., Choi, B., Nam, S.K., Sa, M., Kwon, J.S., et al. 2020. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5, eabd1554.","journal-title":"Sci. Immunol."},{"key":"1525_CR38","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei, X., Dong, X., Ma, R., Wang, W., Xiao, X., Tian, Z., Wang, C., Wang, Y., Li, L., Ren, L., et al. 2020. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 11, 3810.","journal-title":"Nat. Commun."},{"key":"1525_CR39","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K.S.M., Lau, E.H.Y., Wong, J.Y., et al. 2020a. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382, 1199\u20131207.","journal-title":"N. Engl. J. Med."},{"key":"1525_CR40","doi-asserted-by":"crossref","first-page":"198074","DOI":"10.1016\/j.virusres.2020.198074","volume":"286","author":"JY Li","year":"2020","unstructured":"Li, J.Y., Liao, C.H., Wang, Q., Tan, Y.J., Luo, R., Qiu, Y., and Ge, X.Y. 2020b. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway. Virus Res. 286, 198074.","journal-title":"Virus Res."},{"key":"1525_CR41","doi-asserted-by":"crossref","first-page":"e0074721","DOI":"10.1128\/JVI.00747-21","volume":"95","author":"A Li","year":"2021","unstructured":"Li, A., Zhao, K., Zhang, B., Hua, R., Fang, Y., Jiang, W., Zhang, J., Hui, L., Zheng, Y., Li, Y., et al. 2021. SARS-CoV-2 NSP12 protein is not an interferon-\u03b2 antagonist. J. Virol. 95, e0074721.","journal-title":"J. Virol."},{"key":"1525_CR42","doi-asserted-by":"crossref","first-page":"102293","DOI":"10.1016\/j.isci.2021.102293","volume":"24","author":"X Lin","year":"2021","unstructured":"Lin, X., Fu, B., Yin, S., Li, Z., Liu, H., Zhang, H., Xing, N., Wang, Y., Xue, W., Xiong, Y., et al. 2021. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. iScience 24, 102293.","journal-title":"iScience"},{"key":"1525_CR43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41564-021-00884-1","volume":"6","author":"G Liu","year":"2021","unstructured":"Liu, G., Lee, J.H., Parker, Z.M., Acharya, D., Chiang, J.J., van Gent, M., Riedl, W., Davis-Gardner, M.E., Wies, E., Chiang, C., et al. 2021. ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity. Nat. Microbiol. 6, 467\u2013478.","journal-title":"Nat. Microbiol."},{"key":"1525_CR44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11262-010-0544-x","volume":"42","author":"X Lu","year":"2011","unstructured":"Lu, X., Pan, J., Tao, J., and Guo, D. 2011. SARS-CoV nucleocapsid protein antagonizes IFN-\u03b2 response by targeting initial step of IFN-\u03b2 induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes 42, 37\u201345.","journal-title":"Virus Genes"},{"key":"1525_CR45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565\u2013574.","journal-title":"Lancet"},{"key":"1525_CR46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.devcel.2020.12.010","volume":"56","author":"G Miao","year":"2021","unstructured":"Miao, G., Zhao, H., Li, Y., Ji, M., Chen, Y., Shi, Y., Bi, Y., Wang, P., and Zhang, H. 2021. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Dev. Cell 56, 427\u2013442.","journal-title":"Dev. Cell"},{"key":"1525_CR47","doi-asserted-by":"crossref","first-page":"28344","DOI":"10.1073\/pnas.2016650117","volume":"117","author":"L Miorin","year":"2020","unstructured":"Miorin, L., Kehrer, T., Sanchez-Aparicio, M.T., Zhang, K., Cohen, P., Patel, R.S., Cupic, A., Makio, T., Mei, M., Moreno, E., et al. 2020. SARS-CoV-2 Orf6 hijacks Nup98 to block stat nuclear import and antagonize interferon signaling. Proc. Natl. Acad. Sci. USA 117, 28344\u201328354.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1525_CR48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/22221751.2020.1870414","volume":"10","author":"M Moustaqil","year":"2021","unstructured":"Moustaqil, M., Ollivier, E., Chiu, H.P., Van Tol, S., Rudolffi-Soto, P., Stevens, C., Bhumkar, A., Hunter, D.J.B., Freiberg, A.N., Jacques, D., et al. 2021. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): Implications for disease presentation across species. Emerg. Microbes Infect. 10, 178\u2013195.","journal-title":"Emerg. Microbes Infect."},{"key":"1525_CR49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41421-020-00208-3","volume":"6","author":"J Mu","year":"2020","unstructured":"Mu, J., Fang, Y., Yang, Q., Shu, T., Wang, A., Huang, M., Jin, L., Deng, F., Qiu, Y., and Zhou, X. 2020. SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2. Cell Discov. 6, 65.","journal-title":"Cell Discov."},{"key":"1525_CR50","doi-asserted-by":"crossref","first-page":"100925","DOI":"10.1016\/j.jbc.2021.100925","volume":"297","author":"R Mukherjee","year":"2021","unstructured":"Mukherjee, R., Bhattacharya, A., Bojkova, D., Mehdipour, A.R., Shin, D., Khan, K.S., Cheung, H.H.Y., Wong, K.B., Ng, W.L., Cinatl, J., et al. 2021. Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection. J. Biol. Chem. 297, 100925.","journal-title":"J. Biol. Chem."},{"key":"1525_CR51","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/cells10030530","volume":"10","author":"SJ Oh","year":"2021","unstructured":"Oh, S.J. and Shin, O.S. 2021. SARS-CoV-2 nucleocapsid protein targets RIG-I-like receptor pathways to inhibit the induction of interferon response. Cells 10, 530.","journal-title":"Cells"},{"key":"1525_CR52","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","volume":"27","author":"A Park","year":"2020","unstructured":"Park, A. and Iwasaki, A. 2020. Type I and type III interferons \u2014 induction, signaling, evasion, and application to combat COVID-19. Cell Host Microbe 27, 870\u2013878.","journal-title":"Cell Host Microbe"},{"key":"1525_CR53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","volume":"7","author":"S Perlman","year":"2009","unstructured":"Perlman, S. and Netland, J. 2009. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7, 439\u2013450.","journal-title":"Nat. Rev. Microbiol."},{"key":"1525_CR54","doi-asserted-by":"crossref","first-page":"198350","DOI":"10.1016\/j.virusres.2021.198350","volume":"296","author":"F Rashid","year":"2021","unstructured":"Rashid, F., Dzakah, E.E., Wang, H., and Tang, S. 2021. The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta. Virus Res. 296, 198350.","journal-title":"Virus Res."},{"key":"1525_CR55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel, J. and Gack, M.U. 2020. RIG-I-like receptors: Their regulation and roles in RNA sensing. Nat. Rev. Immunol. 20, 537\u2013551.","journal-title":"Nat. Rev. Immunol."},{"key":"1525_CR56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fimmu.2014.00342","volume":"5","author":"S Reikine","year":"2014","unstructured":"Reikine, S., Nguyen, J.B., and Modis, Y. 2014. Pattern recognition and signaling mechanisms of RIG-I and MDA5. Front. Immunol. 5, 342.","journal-title":"Front. Immunol."},{"key":"1525_CR57","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41423-020-0485-9","volume":"17","author":"Y Ren","year":"2020","unstructured":"Ren, Y., Shu, T., Wu, D., Mu, J., Wang, C., Huang, M., Han, Y., Zhang, X.Y., Zhou, W., Qiu, Y., et al. 2020. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell. Mol. Immunol. 17, 881\u2013883.","journal-title":"Cell. Mol. Immunol."},{"key":"1525_CR58","doi-asserted-by":"crossref","first-page":"e150542","DOI":"10.1172\/jci.insight.150542","volume":"22","author":"V Salvi","year":"2021","unstructured":"Salvi, V., Nguyen, H.O., Sozio, F., Schioppa, T., Gaudenzi, C., Laffranchi, M., Scapini, P., Passari, M., Barbazza, I., Tiberio, L., et al. 2021. SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7\/8. JCI Insight 22, e150542.","journal-title":"JCI Insight"},{"key":"1525_CR59","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1038\/s41598-021-92940-3","volume":"11","author":"NG Sampaio","year":"2021","unstructured":"Sampaio, N.G., Chauveau, L., Hertzog, J., Bridgeman, A., Fowler, G., Moonen, J.P., Dupont, M., Russell, R.A., Noerenberg, M., and Rehwinkel, J. 2021. The RNA sensor MDA5 detects SARS-CoV-2 infection. Sci. Rep. 11, 13638.","journal-title":"Sci. Rep."},{"key":"1525_CR60","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider, W.M., Chevillotte, M.D., and Rice, C.M. 2014. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32, 513\u2013545.","journal-title":"Annu. Rev. Immunol."},{"key":"1525_CR61","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41594-020-0511-8","volume":"27","author":"K Schubert","year":"2020","unstructured":"Schubert, K., Karousis, E.D., Jomaa, A., Scaiola, A., Echeverria, B., Gurzeler, L.A., Leibundgut, M., Thiel, V., Muhlemann, O., and Ban, N. 2020. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat. Struct. Mol. Biol. 27, 959\u2013966.","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1525_CR62","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.1303196","volume":"193","author":"CS Shi","year":"2014","unstructured":"Shi, C.S., Qi, H.Y., Boularan, C., Huang, N.N., Abu-Asab, M., Shelhamer, J.H., and Kehrl, J.H. 2014. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS\/TRAF3\/TRAF6 signalosome. J. Immunol. 193, 3080\u20133089.","journal-title":"J. Immunol."},{"key":"1525_CR63","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","volume":"587","author":"D Shin","year":"2020","unstructured":"Shin, D., Mukherjee, R., Grewe, D., Bojkova, D., Baek, K., Bhattacharya, A., Schulz, L., Widera, M., Mehdipour, A.R., Tascher, G., et al. 2020. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 587, 657\u2013662.","journal-title":"Nature"},{"key":"1525_CR64","doi-asserted-by":"crossref","first-page":"e06187","DOI":"10.1016\/j.heliyon.2021.e06187","volume":"7","author":"K Shirato","year":"2021","unstructured":"Shirato, K. and Kizaki, T. 2021. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon 7, e06187.","journal-title":"Heliyon"},{"key":"1525_CR65","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1126\/science.abc8665","volume":"369","author":"M Thoms","year":"2020","unstructured":"Thoms, M., Buschauer, R., Ameismeier, M., Koepke, L., Denk, T., Hirschenberger, M., Kratzat, H., Hayn, M., Mackens-Kiani, T., Cheng, J., et al. 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science 369, 1249\u20131255.","journal-title":"Science"},{"key":"1525_CR66","doi-asserted-by":"crossref","first-page":"e107826","DOI":"10.15252\/embj.2021107826","volume":"40","author":"LG Thorne","year":"2021","unstructured":"Thorne, L.G., Reuschl, A.K., Zuliani-Alvarez, L., Whelan, M.V.X., Turner, J., Noursadeghi, M., Jolly, C., and Towers, G.J. 2021. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J. 40, e107826.","journal-title":"EMBO J."},{"key":"1525_CR67","first-page":"e00638","volume":"6","author":"AL Totura","year":"2015","unstructured":"Totura, A.L., Whitmore, A., Agnihothram, S., Sch\u00e4fer, A., Katze, M.G., Heise, M.T., and Baric, R.S. 2015. Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. mBio 6, e00638\u201315.","journal-title":"mBio"},{"key":"1525_CR68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s10038-020-0808-9","volume":"65","author":"Y Toyoshima","year":"2020","unstructured":"Toyoshima, Y., Nemoto, K., Matsumoto, S., Nakamura, Y., and Kiyotani, K. 2020. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J. Hum. Genet. 65, 1075\u20131082.","journal-title":"J. Hum. Genet."},{"key":"1525_CR69","doi-asserted-by":"crossref","unstructured":"Vazquez, C., Swanson, S.E., Negatu, S.G., Dittmar, M., Miller, J., Ramage, H.R., Cherry, S., and Jurado, K.A. 2021. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS ONE 16, e0253089.","DOI":"10.1371\/journal.pone.0253089"},{"key":"1525_CR70","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41556-021-00710-0","volume":"23","author":"S Wang","year":"2021","unstructured":"Wang, S., Dai, T., Qin, Z., Pan, T., Chu, F., Lou, L., Zhang, L., Yang, B., Huang, H., Lu, H., et al. 2021a. Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity. Nat. Cell Biol. 23, 718\u2013732.","journal-title":"Nat. Cell Biol."},{"key":"1525_CR71","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41423-020-00619-y","volume":"18","author":"W Wang","year":"2021","unstructured":"Wang, W., Zhou, Z., Xiao, X., Tian, Z., Dong, X., Wang, C., Li, L., Ren, L., Lei, X., Xiang, Z., et al. 2021b. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation. Cell. Mol. Immunol. 18, 945\u2013953.","journal-title":"Cell. Mol. Immunol."},{"key":"1525_CR72","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu, Z. and McGoogan, J.M. 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323, 1239\u20131242.","journal-title":"JAMA"},{"key":"1525_CR73","doi-asserted-by":"crossref","first-page":"108761","DOI":"10.1016\/j.celrep.2021.108761","volume":"34","author":"J Wu","year":"2021","unstructured":"Wu, J., Shi, Y., Pan, X., Wu, S., Hou, R., Zhang, Y., Zhong, T., Tang, H., Du, W., Wang, L., et al. 2021. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep. 34, 108761.","journal-title":"Cell Rep."},{"key":"1525_CR74","doi-asserted-by":"crossref","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia, H., Cao, Z., Xie, X., Zhang, X., Chen, J.Y.C., Wang, H., Menachery, V.D., Rajsbaum, R., and Shi, P.Y. 2020. Evasion of type i Interferon by SARS-CoV-2. Cell Rep. 33, 108234.","journal-title":"Cell Rep."},{"key":"1525_CR75","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41590-021-00942-0","volume":"22","author":"T Yamada","year":"2021","unstructured":"Yamada, T., Sato, S., Sotoyama, Y., Orba, Y., Sawa, H., Yamauchi, H., Sasaki, M., and Takaoka, A. 2021. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. Nat. Immunol. 22, 820\u2013828.","journal-title":"Nat. Immunol."},{"key":"1525_CR76","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","volume":"6","author":"L Yang","year":"2021","unstructured":"Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., and Zhou, Y. 2021. The signal pathways and treatment of cytokine storm in COVID-19. Sig. Transduct. Target. Ther. 6, 255.","journal-title":"Sig. Transduct. Target. Ther."},{"key":"1525_CR77","doi-asserted-by":"publisher","unstructured":"Yang, Z., Zhang, X., Wang, F., Wang, P., Kuang, E., and Li, X. 2020. Suppression of MDA5-mediated antiviral immune responses by NSP8 of SARS-CoV-2. bioRxiv. doi: https:\/\/doi.org\/10.1101\/2020.08.12.247767.","DOI":"10.1101\/2020.08.12.247767"},{"key":"1525_CR78","doi-asserted-by":"crossref","first-page":"108628","DOI":"10.1016\/j.celrep.2020.108628","volume":"34","author":"X Yin","year":"2021","unstructured":"Yin, X., Riva, L., Pu, Y., Martin-Sancho, L., Kanamune, J., Yamamoto, Y., Sakai, K., Gotoh, S., Miorin, L., De Jesus, P.D., et al. 2021. MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep. 34, 108628.","journal-title":"Cell Rep."},{"key":"1525_CR79","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1080\/22221751.2020.1780953","volume":"9","author":"CK Yuen","year":"2020","unstructured":"Yuen, C.K., Lam, J.Y., Wong, W.M., Mak, L.F., Wang, X., Chu, H., Cai, J.P., Jin, D.Y., To, K.K.W., Chan, J.F.W., et al. 2020. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg. Microbes Infect. 9, 1418\u20131428.","journal-title":"Emerg. Microbes Infect."},{"key":"1525_CR80","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I.K.D., Hodeib, S., Korol, C., et al. 2020. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570.","journal-title":"Science"},{"key":"1525_CR81","doi-asserted-by":"crossref","first-page":"e2024202118","DOI":"10.1073\/pnas.2024202118","volume":"118","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Chen, Y., Li, Y., Huang, F., Luo, B., Yuan, Y., Xia, B., Ma, X., Yang, T., Yu, F., et al. 2021a. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-I. Proc. Natl. Acad. Sci. USA 118, e2024202118.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1525_CR82","doi-asserted-by":"crossref","first-page":"eabe7386","DOI":"10.1126\/sciadv.abe7386","volume":"7","author":"K Zhang","year":"2021","unstructured":"Zhang, K., Miorin, L., Makio, T., Dehghan, I., Gao, S., Xie, Y., Zhong, H., Esparza, M., Kehrer, T., Kumar, A., et al. 2021b. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression. Sci. Adv. 7, eabe7386.","journal-title":"Sci. Adv."},{"key":"1525_CR83","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","volume":"31","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y., Kuang, M., Li, J., Zhu, L., Jia, Z., Guo, X., Hu, Y., Kong, J., Yin, H., Wang, X., et al. 2021a. SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 31, 818\u2013820.","journal-title":"Cell Res."},{"key":"1525_CR84","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41392-021-00742-w","volume":"6","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y., Sui, L., Wu, P., Wang, W., Wang, Z., Yu, Y., Hou, Z., Tan, G., Liu, Q., and Wang, G. 2021b. A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response. Sig. Transduct. Target. Ther. 6, 331.","journal-title":"Sig. Transduct. Target. Ther."},{"key":"1525_CR85","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","volume":"22","author":"M Zheng","year":"2021","unstructured":"Zheng, M., Karki, R., Williams, E.P., Yang, D., Fitzpatrick, E., Vogel, P., Jonsson, C.B., and Kanneganti, T.D. 2021. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 22, 829\u2013838.","journal-title":"Nat. Immunol."},{"key":"1525_CR86","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41392-020-00438-7","volume":"5","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y., Zhuang, M.W., Han, L., Zhang, J., Nan, M.L., Zhan, P., Kang, D., Liu, X., Gao, C., and Wang, P.H. 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I\/MDA-5 signaling. Sig. Transduct. Target. Ther. 5, 299.","journal-title":"Sig. Transduct. Target. Ther."},{"key":"1525_CR87","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L., et al. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273.","journal-title":"Nature"},{"key":"1525_CR88","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. 2020. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733.","journal-title":"N. Engl. J. Med."},{"key":"1525_CR89","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler, C.G.K., Allon, S.J., Nyquist, S.K., Mbano, I.M., Miao, V.N., Tzouanas, C.N., Cao, Y., Yousif, A.S., Bals, J., Hauser, B.M., et al. 2020. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016\u20131035.","journal-title":"Cell"},{"key":"1525_CR90","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41556-021-00712-y","volume":"23","author":"A Zotta","year":"2021","unstructured":"Zotta, A., Hooftman, A., and O\u2019Neill, L.A.J. 2021. SARS-CoV-2 targets MAVS for immune evasion. Nat. Cell Biol. 23, 682\u2013683.","journal-title":"Nat. Cell Biol."}],"container-title":["Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-022-1525-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12275-022-1525-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-022-1525-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:51:41Z","timestamp":1735062701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12275-022-1525-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,5]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1525"],"URL":"https:\/\/doi.org\/10.1007\/s12275-022-1525-1","relation":{},"ISSN":["1225-8873","1976-3794"],"issn-type":[{"value":"1225-8873","type":"print"},{"value":"1976-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,5]]},"assertion":[{"value":"8 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}